Astillero, Ryan E.

HRN: 28-51-14  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2026
CEFUROXIME 1.5GM (VIAL)
01/31/2026
02/07/2026
IV
1.5g
Q8
Laceration
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines